// App-Quantinova.ai

1960 : Initiation of Tumor Necrosis Factor Alpha (TNF?) Antagonists and Risk of Fractures in Patients with Selected Rheumatic and Autoimmune Diseases

Researchers

Presenter

  • Vivian K. Kawai

Principal Investigators

  • Carlos Grijalva

  • Patrick Arbogast

  • Marie Griffin

  • Jeffrey R. Curtis

  • Daniel H. Solomon

  • Elizabeth S. Delzell

  • Lang Chen

  • Lisa Herrinton

  • Liyan Liu

  • Edward F. Mitchell Jr

  • C. Michael Stein

Medical Centers

  • School of Medicine, Division of Clinical Pharmacology, Vanderbilt Medical Center, Nashville, TN

  • Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL

  • Dept of epidemiology, Univ of Alabama at Birmingham, Birmingham, AL

  • Division of Research, Kaiser Permanente, Oakland, CA

  • Vanderbilt University, Nashville, TN

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA

  • Internal Medicine, Vanderbilt University, Nashville, TN

  • Rheumatology & Immunology, Univ of Alabama-Birmingham, Birmingham, AL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • Hydroxychloroquine

  • HWA-486

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved